tirzepatide brighton FDA Grants a New Indication for Obesity Management GLP-1 medications are about more

Maintaining adequate hydration is important to prevent acute kidney injury, especially if experiencing gastrointestinal side effects

Discontinuation rates in Phase 3 were 12.2% at the 9mg dose and 18.2% at 12mg, compared to 4% on placebo

This supports expanding its use to all overweight or obese patients with atherosclerotic cardiovascular disease, revising BMI-based prescription limits to focus on reducing cardiovascular risk, and positioning GLP-1RAs as an important part of secondary prevention for heart disease

These findings emphasize the distinct metabolic profiles of T2DM mice and suggest possible variations in response to different antidiabetic therapies